BEI
ONC

Benjamin Edwards Inc’s BeOne Medicines Ltd ONC Stock Holding History

Benjamin Edwards Inc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231K Buy
778
+88
+13% +$28.5K ﹤0.01% 1266
2025
Q4 		$210K Buy
690
+51
+8% +$16.7K ﹤0.01% 1252
2025
Q3 		$218K Buy
+639
New +$194K ﹤0.01% 1220

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Benjamin Edwards Inc's ONC Position: Q1 2026 in Review

Benjamin Edwards Inc increased its BeOne Medicines Ltd (ONC) stake by 13% in Q1 2026, buying an estimated $28.5K and bringing the position to 778 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Benjamin Edwards Inc first reported a position in ONC in Q3 2025 and has held it in 3 quarters since. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Benjamin Edwards Inc held 778 shares of BeOne Medicines Ltd worth $231K as of Q1 2026.
  • Benjamin Edwards Inc bought 88 BeOne Medicines Ltd shares in Q1 2026, an estimated $28.5K.
  • BeOne Medicines Ltd made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q1 2026, its #1266 holding.
  • Benjamin Edwards Inc first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 3 quarters since.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Benjamin Edwards Inc's 13F filing for Q1 2026, filed 12 May 2026.